Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

REPLIGEN CORPORATION

(RGEN)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur REPLIGEN CORPORATION
12/01Repligen Seeks Acquisitions
04/01REPLIGEN CORP : Change in Directors or Principal Officers, Financial Statements and Exhibi..
04/01Repligen Corporation Promotes James Bylund to the Chief Operating Officer and Principal..
2021Repligen Corporation to Present at 40th Annual J.P. Morgan Healthcare Conference
2021REPLIGEN CORP : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ..
2021Repligen Corporation acquired Bio-Flex Solutions, L.L.C. / Newton T & M Corp.
2021INSIDER SELL : Repligen
2021INSIDER SELL : Repligen
2021Repligen Corporation to Present at Upcoming Investor Conferences
2021Repligen Releases Inaugural Sustainability Report
2021Repligen Releases Inaugural Sustainability Report
2021INSIDER SELL : Repligen
2021INSIDER SELL : Repligen
2021REPLIGEN CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
2021Tranche Update on Repligen Corporation's Equity Buyback Plan announced on June 18, 2008..
2021Repligen Corporation Reports Earnings Results for the Third Quarter and Nine Months End..
2021Repligen Q3 Adjusted Earnings, Revenue Jump; Company Lifts 2021 Outlook
2021Repligen Reports Third Quarter 2021 Financial Results and Updates Full Year 2021 Financ..
2021REPLIGEN : Q3 Earnings Snapshot
2021Repligen Corporation Provides Earnings Guidance for the Fiscal Year 2021
2021Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q3 EPS $0.78, vs. Street Est of $0.6..
2021Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q3 Revenue $178.2M, vs. Street Est of ..
2021Repligen Reports Third Quarter 2021 Financial Results and Updates Full Year 2021 Financ..
2021Los valores del Nasdaq con mayor crecimiento
2021REPLIGEN : to Report Third Quarter 2021 Financial Results
2021Repligen Corporation completed the acquisition of Avitide, Inc.
2021VC DAILY : Question: What's Top of Mind for VCs as the Fourth Quarter Approaches?
2021REPLIGEN : to Acquire Chromatography Developer Avitide in $150 Million Cash-And-Stock Deal
2021REPLIGEN : Announces Agreement to Acquire Avitide Inc (Form 8-K)
2021REPLIGEN CORP : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ..
2021Repligen Announces Agreement to Acquire Avitide Inc.
2021Repligen Corporation agreed to acquire Avitide, Inc. for approximately $280 million.
2021INSIDER SELL : Repligen
2021REPLIGEN : and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purifica..
2021REPLIGEN : and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purifica..
2021Repligen Corporation and Navigo GmbH Announce Launch of Industry-First Protein A Ligand..
2021REPLIGEN : Extends Long Term Supply Agreement with Cytiva for Affinity Ligands
2021REPLIGEN CORP : Other Events (form 8-K)
2021Repligen Corporation Extends Through 2025 A Long-Term Supply Agreement with Cytiva Swed..
2021INSIDER SELL : Repligen
2021INSIDER TRENDS : Insider Sales Continue 90-Day Trend at Repligen
2021INSIDER TRENDS : Selling By Insiders Lingers at Repligen
2021REPLIGEN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPER..
2021Tranche Update on Repligen Corporation's Equity Buyback Plan announced on June 18, 2008..
2021REPLIGEN : Reports Higher Q2 Earnings, Revenue From 2020 Levels, Raises Full-Year Outlook
2021REPLIGEN : Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Financ..
2021Repligen Corporation Reports Earnings Results for the Second Quarter Ended June 30, 202..
2021REPLIGEN : Q2 Earnings Snapshot
2021Repligen Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Finan..
2021REPLIGEN : Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q2 EPS $0.79, vs. Street Est o..
2021REPLIGEN : Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q2 Revenue $163M, vs. Street..
2021Repligen Corporation Revises Earnings Guidance for the Year 2021
2021INSIDER TRENDS : Repligen Insider Extends 90-Day Selling Trend
2021Repligen to Report Second Quarter 2021 Financial Results
2021Repligen Corporation completed the acquisition of Polymem S.A.
2021REPLIGEN CORPORATION(NASDAQGS : RGEN) added to Russell Midcap Value Index
2021REPLIGEN CORPORATION(NASDAQGS : RGEN) added to Russell 3000 Value Index
2021REPLIGEN CORPORATION(NASDAQGS : RGEN) added to Russell 3000E Value Index
2021REPLIGEN CORPORATION(NASDAQGS : RGEN) added to Russell 1000 Value Index
2021REPLIGEN CORPORATION(NASDAQGS : RGEN) added to Russell Small Cap Comp Value Index
2021REPLIGEN CORPORATION(NASDAQGS : RGEN) added to Russell 2500 Value Index
2021REPLIGEN : To Buy Polymem For Undisclosed Sum
2021Repligen Corporation Announces Agreement to Acquire Polymem S.A.
2021Repligen Corporation entered into an agreement to acquire Polymem S.A.
2021Repligen Corporation to Present at Upcoming Investor Conferences
2021REPLIGEN : Continued Level of Significant Insider Selling at Repligen (RGEN)
2021INSIDER TRENDS : Insider Sales Continue 90-Day Trend at Repligen
2021REPLIGEN CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
2021INSIDER TRENDS : Insider Sale at Repligen Slowing 90-Days of Buying
2021REPLIGEN : 2020 Annual Report (PDF)
2021REPLIGEN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPER..
2021Tranche Update on Repligen Corporation's Equity Buyback Plan announced on June 18, 2008..
2021REPLIGEN : Posts Rise in Q1 Adjusted Profit, Revenue; Amends 2021 Forecasts
2021REPLIGEN : Reported revenue was $142.8 million for the quarter, representing year-over-yea..
2021REPLIGEN : Q1 Earnings Snapshot
1  2  3  4  5  6  7Suiv.
Prochain événement sur REPLIGEN CORPORATION